Trastuzumab in Early-Stage Breast Cancer
Funding a Clinical Trial
Unrelated Medical Costs in Life-Years Gained
Quality-of-Life Assessment in Rheumatoid Arthritis
Multiple Sclerosis in the UK
Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland
Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure
Assessing the Value of a Future Study
The Authors’ Reply